Evidence map›Paper›PMID 17932576›Full record

ArticleThe Canadian journal of cardiology2007

Nitroglycerine causes mitochondrial reactive oxygen species production: in vitro mechanistic insights.

Tommaso Gori, Andreas Daiber, Giuseppe Di Stolfo, Silvia Sicuro, Saverio Dragoni, Monica Lisi, Thomas Münzel, Sandro Forconi, John D Parker

Open access · bronzeAbstract read
In one paragraph

Article in The Canadian journal of cardiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis.International journal of molecular sciences · 2020
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Tommaso GoriDepartment of Internal, Cardiovascular and Geriatric Medicine, University of Siena, Italy, and Department of Medicine, Mount Sinai and University Health Network Hospitals, Toronto, Ontario, Canada.
Andreas Daiber
Giuseppe Di Stolfo
Silvia Sicuro
Saverio Dragoni
Monica Lisi
Thomas Münzel
Sandro Forconi
John D Parker
University of Siena · ITJohannes Gutenberg University Mainz · DEUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNitroglycerine (GTN) is an organic nitrate that has been used for more than 100 years. Despite its widespread clinical use, several aspects of the pharmacology of GTN remain elusive. In a recent study, the authors of the present study showed that GTN causes opening of the mitochondrial permeability transition pore (mPTP) and mitochondrial production of reactive oxygen species (ROS).

objectiveIn the present study, it was tested whether GTN-induced ROS production depends on mitochondrial potassium ATP-dependent channel or mPTP opening, and/or GTN biotransformation. METHODS AND

resultsIsolated rat heart mitochondria were incubated with succinate (a substrate for complex II) and GTN, causing immediate ROS production, as manifested by chemiluminescence. This ROS production was prevented by concomitant vitamin C incubation. Conversely, inhibitors of potassium ATP-dependent channels, mPTP opening or of GTN biotransformation did not modify ROS production.

conclusionsGTN triggers mitochondrial ROS production independently of the opening of mitochondrial channels and/or of GTN biotransformation. The present data, coupled with previous evidence published by the same authors that GTN causes opening of mPTPs, provide further evidence on the pharmacology of GTN. It is proposed that GTN causes direct uncoupling of the respiratory chain, which determines ROS production and subsequent mPTP opening. The clinical implications of these findings are also discussed.

Indexed as

AnimalsBiotransformationIn Vitro TechniquesKATP ChannelsMitochondria, HeartMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreModels, AnimalNitroglycerinPotassium ChannelsRatsRats, WistarReactive Oxygen SpeciesVasodilator AgentsKATP ChannelsMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreNitroglycerinPotassium ChannelsReactive Oxygen SpeciesVasodilator Agents

Identifiers

PMID17932576
PMCPMC2651423
OpenAlexW1985274709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.